Filed before 2025Filed 14 January 2020
Valanbio Therapeutics, Inc. has sold $421K so far
Valanbio Therapeutics, Inc., a pharmaceuticals company based in Raleigh, NC, has sold $421K so far in its debt round, according to a filing dated 14 January 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 14 January 2020
- First filed
- 6 September 2019
- Round
- Debt round (amended filing)
- Amount sold
- $421K
- Offering size
- $600K
- Investors so far
- 5
- Based in
- Raleigh, NC
Investors on the board
- oneworld BEV
- BEV Follow-On
- Breakthrough Energy Ventures
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 4% of the 1,744 tracked raises with an amount filed in 2020, and than 2% of the 40 in pharmaceuticals.
Valanbio Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 14 Jan 2020 | Amended filing | $421K | This raise |
| 6 Sep 2019 | New filing | $121K | This raise |
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.